GlassScriptPhysician profile
Jacqui Fisch
NPI 1477562858
$702.72
in general payments reported to CMS, 2019-2025
14 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $80.12 · 2021: $152 · 2022: $88.49 · 2023: $105 · 2024: $51.70 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $262.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $220.73 | 2019-2023 | |
| Pfizer INC. | $88.91 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $66.29 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.59 | 2019-2021 | |
| Astellas Pharma US INC | $51.93 | 2019-2023 | Veozah |
| Millicent US INC | $38.09 | 2020-2025 | Femlyv |
| Exeltis, USA INC. | $35.52 | 2025 | Slynd, Twirla |
| Merck Sharp & Dohme LLC | $32.97 | 2021-2025 | Gardasil 9 |
| Allergan, INC. | $22.82 | 2019-2020 | |
| Shield Therapeutics INC | $19.31 | 2024 | |
| Smith+Nephew, INC. | $19.28 | 2025 | Pico 14, Pico 7 |
| Abbott Laboratories | $17.96 | 2023 | Freestyle Libre 3 |
| Scynexis, INC. | $12.63 | 2022 | |
| Avanos Medical | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqui Fisch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.